Communiqués AZITRAPAR

Actions

AZTR

US05479L1044

Marché Fermé - Nyse Autres places de cotation 22:00:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
0,0922 ^USD	-30,15%		-32,31%	-89,98%

10/05	Azitra, Inc. Azitra Inc. annonce des données précliniques positives sur l'ATR-12 et un plan clinique dans le syndrome de Netherton présenté à la réunion annuelle de l'ASGCT	CI
09/05	Azitra, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Azitra, Inc. Announces Reverse Stock Split	27/06	BU
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention	03/06	AQ
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention	31/05	BU
Azitra Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting	20/05	AQ
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting	17/05	BU
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	13/05	AQ
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	10/05	BU
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates	09/05	BU
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting	22/04	BU
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024	18/04	BU
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates	15/03	BU
Azitra, Inc. Announces Closing of Public Offering	16/02	BU
Azitra, Inc. Announces Pricing of Public Offering	14/02	BU
Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US	16/01	BU
Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference	03/01	BU
Azitra, Inc. Announces Third Quarter 2023 Financial Results and Business Updates	14/11	BU
Azitra to Present at the ThinkEquity Conference	16/10/23	BU
BigTime Penny Stocks: Bottom Fishing Small Caps (ARBB, CMND, AZTR, INBS, LGHL)	09/10/23	AQ
Azitra to Present at the H.C. Wainwright 25th Annual Global Investment Conference	30/08/23	AQ
Azitra, Inc. Announces Second Quarter 2023 Financial Results and Business Updates	15/08/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués AZITRAPAR

Actions

AZTR

US05479L1044

Communiqués

Filtres